Northern Territory Government v Collins: Clayton Utz successfully defended the Northern Territory Government in one of the very few patent cases to reach our highest court, the High Court of Australia. The case concerned the production of essential oils from trees removed from Crown land pursuant to statutory licences.
This matter is significant not only because patent disputes of this type are rarely argued at all, let alone considered by the High Court of Australia, but also because it involves issues of the potential liability of parties for others' patent infringements.
The litigation will have a significant impact on the way governments manage their profitable bio-prospecting regimes (the search for chemical compounds from biological resources, which are often used to create pharmaceutical and agrochemical products).
Pharmaceutical company: We acted for a leading pharmaceutical company in successfully opposing the entry of numerous generic competitors to its gemcitabine hydrochloride products.
Genetic modification: We acted in pioneering patent litigation in the Federal Court relating to patents for the genetic modification of cotton and corn plants. This matter was part of worldwide litigation involving the same suite of patents.
Medical device company: We advised a medical device company on certain issues arising as a result of litigation concerning patents for its dialysis machines.
Equine worming: Federal Court proceedings appealing a decision of the Patents Office concerning an equine worming preparation.
Mining industry technology: Acting in patent infringement proceedings as part of a dispute in the USA and Australia involving mining industry technology. The matter involves allegations of invalidity, and an issue about the breadth of the claims for divisional applications.
Erythropoietin: We provided expert witness assistance in relation to a US patent dispute relating to erythropoietin.
Patent infringement and revocation proceeding: We provided expert witness assistance in relation to a Canadian pharmaceutical patent infringement and revocation proceeding.
Anti-cancer agent: We advised an Australian-based pharmaceutical company in relation to patents for a method of administering an anti-cancer agent.
Osteoporosis and bone disorders: We advised a large US pharmaceutical company regarding pharmaceutical patents directed to treatments for osteoporosis and bone disorders.
Ophthalmic technology: We represented an Australian company with respect to cutting edge patented ophthalmic technology.
Plant breeders rights: We represented a US university and advised in relation to the commercialisation and management of its plant breeders rights in Australia.
Mechanical patent matters: Advised on a number of mechanical patent matters concerning machinery and components in relation to air conditioning systems and ducting for power stations.
Pre-paid call access information technology system: Acted in a patent infringement action brought in the Federal Court of Australia for infringement of an Innovation Patent directed to a real time pre-paid call access information technology system.
|
|
|
|
|
